Featured Firms
Presented by BigVoodoo
Biotech titans Genentech and Chiron began slugging it out in federal court in Sacramento, Calif., Tuesday as both sides told a jury they had invented the technology underlying Genentech's Herceptin breast cancer drug. The case is one of the largest patent disputes involving questions over early research in the biotechnology field, and hundreds of millions of dollars in potential royalties are at stake.
August 07, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS